- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2288
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
What does a modified-Fibonacci dose-escalation actually correspond to? ; volume:12 ; number:1 ; day:23 ; month:7 ; year:2012 ; pages:1-5 ; date:12.2012
BMC medical research methodology ; 12, Heft 1 (23.7.2012), 1-5, 12.2012
- Urheber
-
Penel, Nicolas
- Beteiligte Personen und Organisationen
-
Kramar, Andrew
SpringerLink (Online service)
- DOI
-
10.1186/1471-2288-12-103
- URN
-
urn:nbn:de:1111-2016032133008
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:56 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Penel, Nicolas
- Kramar, Andrew
- SpringerLink (Online service)
Ähnliche Objekte (12)
Incoherent dose-escalation in phase I trials using the escalation with overdose control approach
Phase I dose-escalation oncology trials with sequential multiple schedules
PK/PD modeling supports the dose-escalation decision in VIKING
Intravesical liposomal tacrolimus for hemorrhagic cystitis: a phase 2a multicenter dose-escalation study
Fibonacci.
On Fibonacci functions with Fibonacci numbers
Fibonacci numbers
Kleine Fibonacci
Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress
Mesenchymal Stem Cell Therapy in Acute Intracerebral Hemorrhage: A Dose-Escalation Safety and Tolerability Trial
A dose-escalation ex vivo study on the effects of intracameral benzalkonium chloride in rabbits
Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine
Incoherent dose-escalation in phase I trials using the escalation with overdose control approach
Phase I dose-escalation oncology trials with sequential multiple schedules
PK/PD modeling supports the dose-escalation decision in VIKING
Intravesical liposomal tacrolimus for hemorrhagic cystitis: a phase 2a multicenter dose-escalation study
Fibonacci.
On Fibonacci functions with Fibonacci numbers
Fibonacci numbers
Kleine Fibonacci
Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress
Mesenchymal Stem Cell Therapy in Acute Intracerebral Hemorrhage: A Dose-Escalation Safety and Tolerability Trial
A dose-escalation ex vivo study on the effects of intracameral benzalkonium chloride in rabbits
Phase 1 dose-escalation trial evaluating a group 2 influenza hemagglutinin stabilized stem nanoparticle vaccine
Incoherent dose-escalation in phase I trials using the escalation with overdose control approach
Phase I dose-escalation oncology trials with sequential multiple schedules
PK/PD modeling supports the dose-escalation decision in VIKING
Intravesical liposomal tacrolimus for hemorrhagic cystitis: a phase 2a multicenter dose-escalation study
Fibonacci.
On Fibonacci functions with Fibonacci numbers
Fibonacci numbers
Kleine Fibonacci
Coenzyme Q10 dose-escalation study in hemodialysis patients: safety, tolerability, and effect on oxidative stress
Mesenchymal Stem Cell Therapy in Acute Intracerebral Hemorrhage: A Dose-Escalation Safety and Tolerability Trial
A dose-escalation ex vivo study on the effects of intracameral benzalkonium chloride in rabbits